ABSTRACT
INTRODUCTION
Human beings are colonized by a myriad of microorganisms that interact with each other and with the host in a symbiotic manner, constituting an integrated and functional ecosystem (microbiota) that can influence health as well as disease (1, 2) . In particular, gastrointestinal microbiota can modulate cancer risk within the gastrointestinal tract (3) . Most research today has focused on colon microbiota and its relationship with colorectal cancer (4) and has rarely examined gastric microbiota. Historically, the stomach was considered as a sterile organ due to acid production.
The discovery of Helicobacter pylori (H. pylori) demolished this belief and, for many years, this bacterium was thought to be the only bacteria able to survive in the stomach. However, recent evidence suggests that other bacteria besides H. pylori flourish despite the hostile environment, and gastric microbiota is, actually, more diverse and complex than once thought. Its composition can be shaped by the host physiology as well as by external factors such as diet, H. pylori infection, enteral feeding, proton pump inhibitors, antibiotics and disease (5).
Correa's model of gastric carcinogenesis postulated that chronic H. pylori infection of the gastric mucosa progresses through the stages of chronic active gastritis, atrophic gastritis, intestinal metaplasia, dysplasia and, ultimately, gastric cancer (6) . Today, H. pylori is clearly identified as the strongest risk factor for gastric cancer (7, 8) , the fourth most common malignancy and the second leading cause of cancer-related mortality worldwide (9, 10) .
However, only 1-2% of infected people develop gastric cancer (11) , and its pathogenic mechanisms are unclear. It is possible that gastric microbiota constitutes the link between H. pylori and gastric carcinogenesis, when other bacteria colonize the stomach under conditions of decreased acidity (such as chronic atrophic gastritis), creating reactive oxygen and nitrogen species and modulating inflammatory responses (12, 13) . Therefore, it is important to unravel the significance of specific microbiota to determine which ones are causative of gastric cancer and which are present merely as a consequence in order to develop novel prevention and treatment strategies.
This systematic review aims to provide an update of recent findings related to the role of gastric microbiota in gastric carcinogenesis, focusing on microorganisms besides H. pylori to understand how the constitution of microbiota can influence cancer risk and how it is affected by H. pylori status, possibly explaining its pathogenesis.
METHODS
A comprehensive search was performed using PubMed and the following query (date of last search 5 th August 2015): ("microbiome" OR "microbiota" OR "microflora" OR "bacterial flora" OR "bacterial community") AND ("gastric" OR "stomach" OR "upper digestive tract" OR "upper gastrointestinal tract") AND ("cancer" OR "neoplasia" OR "malignancy" OR "tumor" OR "carcinoma" OR "adenocarcinoma" OR "lymphoma" OR "premalignancy" OR "premalignant" OR "tumorigenesis" OR "carcinogenesis" OR "intestinal metaplasia" OR "atrophic gastritis" OR "Helicobacter pylori" OR "H. pylori").
In the first phase, titles and abstracts were screened by two reviewers, according to specific criteria defined in order to guide this systematic review. Any disagreement was resolved by a third independent reviewer. We included studies presenting information about the role of gastric microbiota beyond H. pylori in gastric carcinogenesis or presenting information about the influence of H. pylori in the constitution of gastric microbiota. The exclusion criteria were: articles published before 2005 (because the constitution of gastric microbiota has been defined more accurately approximately since this year, as previous studies were based on methods with limitations in sensitivity and coverage when compared with more recent approaches); articles not written in English, Portuguese or Spanish; studies performed in animals; studies performed in cell culture models; non-original studies (reviews and case reports).
In the next phase, full-texts of the selected references were assessed and references of included studies were checked to identify additional articles.
Data about bacterial species studied and results obtained were extracted from each article, mentioning methods and main limitations when relevant. The information was then summarised and organized in the present systematic review.
RESULTS

Characteristics of included studies
A total of 300 articles were obtained from the search of the database. After screening by title and abstract, 16 studies were selected for full-text reading, after which, 5 studies were further excluded and 2 studies included by cross-reference. Thirteen articles were finally included (Fig. 1) . Their general characteristics are summarized in table I.
Influence of normal gastric microbiota by H. pylori
Characterization of gastric microbiota in subjects with and without H. pylori could provide new insight into the mechanisms behind a hypothetical cross-talk between this bacterium and the remaining bacterial community and its possible link with gastric carcinogenesis. However, the effect of H. pylori on the microbiota of the human stomach has been examined in very few studies.
H. pylori and gastric microbiota in adults
In 2006, Bik et al. characterized bacterial diversity within the human gastric mucosa using a small subunit 16S rDNA clone library approach. This group analyzed 1,833 sequences generated by broad-range bacterial PCR from gastric biopsy samples of 23 individuals. A diverse gastric bacterial community of 128 phylotypes was dominated by 5 major phyla: Proteobacteria (952 clones, 32 phylotypes), Firmicutes (464 clones, 36 phylotypes), Bacteroidetes (193 clones, 35 phylotypes), Actinobacteria (164 clones, 12 phylotypes), and Fusobacteria (56 clones, 10 phylotypes). H. pylori was the only member of the genus Helicobacter found; the sequences were found in 19 of the 23 samples analyzed and constituted 42% of all sequences analyzed (777 clones), making this the most abundant genus followed by Streptococcus (299 clones) and Prevotella (139 clones). Interestingly, its presence did not affect significantly the composition of gastric microbiota, although H. pylori-positive subjects demonstrated a relative lack of non-Proteobacteria phylotypes, especially Bacteroidetes (p > 0.05) (14) . Full-text articles assessed for eligibility (16) Studies included in qualitative analysis (13) (16) .
In 2011, Maldonado-Contreras et al. characterized the structure of the human gastric bacterial community in relation to H. pylori status in 12 adult patients (10 Amerindians and 2 non-Amerindians) using a high-density 16S rRNA gene microarray. A total of 44 bacterial phyla were detected in an uneven ecosystem, with a strong dominance of only four phyla: Proteobacteria, Firmicutes, Actinobacteria and Bacteroidetes (in descending order). Positive H. pylori status was significantly associated with increased relative abundance of non-Helicobacter bacteria from the Proteobacteria, Spirochetes and Acidobacteria, and with decreased abundance of Actinobacteria, Bacteroidetes and Firmicutes. In fact, about 28% of the total variance in the gastric microbiota of the 12 subjects was explained by H. pylori status, although a larger fraction (44%) was related to the ethnicity of the subjects, stressing the need for conducting larger studies of different human populations (17).
More recently, other studies based on bacterial cultures analyzed by matrix-assisted laser desorption ionizationtime-of-flight mass spectrometry (MALDI-TOF MS) allow high accuracy and rapid analysis of a large number of samples (18, 19 (14) . Similarly, Maldonado-Contreras et al. did not report a variation in the absolute number of non-H. pylori bacteria present but found that H. pylori resulted in differences in the relative abundance of several phyla (17).
Predominant phyla were Firmicutes (270 colonies from 208 positive biopsies) and Proteobacteria (220 colonies from 160 biopsies) while Actinobacteria were rare (53 colonies from 43 biopsies). At the genus level, Streptococcus were predominant (121 positive biopsies) followed by Neisseria (44 positive biopsies), Klebsiella (42 positive biopsies) and Lactobacillus (42 positive biopsies) (19) . These results are consistent with previous studies reporting that Proteobacteria, Firmicutes, Actinobacteria and Bacteroidetes are the predominant phyla in human gastric microbiota (14-17), overcoming the important limitation of the small number of human samples (6-23 individuals) in these studies. Nevertheless, the approach adopted by Khosravi et al. still excludes non-cultivable bacteria.
Eun et al. also analyzed the gastric microbiota profile according to H. pylori status using high-throughput 16S rRNA sequencing, in biopsy samples collected from 31 patients (11 with noncardia gastric cancer, 10 with intestinal metaplasia, and 10 with chronic gastritis) during endoscopy. The relative abundance of the families Bradyhizobiaceae, Caulobacteraceae, Lactobacillaceae, and Burkholderiaceae was significantly higher in H. pylori-negative patients, whereas the relative abundance of the Helicobacteriaceae family was significantly higher in H. pylori-positive patients (20) . 
H. pylori and gastric microbiota in children
Information about gastric microbiota in children is even more limited; to date, only Kato et al. addressed this question by comparing gastric microbiota in 10 children and 10 adults presenting with dyspeptic symptoms in relation to H. pylori status (5 H. pylori-infected and 5 uninfected in each group) using both culture and RT-PCR techniques. An overall colonization rate of non-Helicobacter bacteria in gastric mucosa was higher in adults (100%) than in children (10%) (p < 0.001). Also, there was no significant difference between adults with H. pylori infection and those without (p = 0.056). This demonstrates that, regardless of H. pylori status, bacteria reside on the gastric mucosa of adults, although such microorganisms rarely colonize the stomach of children (21) .
The role of microbiota in the development of gastric cancer
The very few studies that compare the constitution of gastric microbiota between gastric cancer patients and controls, in order to establish whether there are significant differences that could support a possible causal role for these bacteria, are analyzed in this section.
Global gastric microbiota diversity and gastric cancer
Avilés-Jiménez et al. analyzed the constitution of gastric microbiota in five patients, each with non-atrophic gastritis, intestinal metaplasia and gastric cancer, and observed low gastric microbiota diversity in all three disease groups: two phyla, Firmicutes and Proteobacteria, represented almost 70% of microbial community while 9 families represented on average 55.6% of each sample's operational taxonomic units (OTU), with Lachnospiraceae and Streptococacceae representing over 20% of the microbiota. In addition, although significant differences in bacterial diversity were noted between non-atrophic gastritis and gastric cancer (p = 0.004) but not between intestinal metaplasia and any other group, a decreasing trend from non-atrophic gastritis to intestinal metaplasia to gastric cancer was observed (22) .
A cross-sectional study involving 720 Chinese healthy volunteers performed by Yu et al. supports the idea that decreased gastric microbial diversity could favor the development of gastric cancer. This study found a linear relationship between microbial richness and pepsinogen I/pepsinogen II ratio. Therefore, lower gastric microbial richness is associated with a lower pepsinogen I/pepsinogen II ratio, which is a marker for chronic atrophic gastritis, a cancer-predisposing condition in the stomach (23) .
However, Eun et al. compared gastric microbiota between patients with gastric cancer, intestinal metaplasia and chronic gastritis and reported that the evenness and diversity of gastric microbiota was significantly increased in gastric cancer (20) .
Specific changes in microbiota possibly related to gastric carcinogenesis
Dicksved et al. contributed the first DNA-based description of a complex gastric bacterial community in individuals with gastric cancer with potential as a maintainer or bystander in the progression of neoplasia. This group compared the gastric microbiota of 10 patients with gastric cancer with that of 5 dyspeptic controls with normal mucosa using terminal restriction fragment length polymorphism (T-RFLP) in combination with 16S rRNA gene cloning and sequencing. Sequencing of 140 clones revealed 102 phylotypes, with representatives from five bacterial phyla: Firmicutes (60%), Bacteroidetes (11%), Actinobacteria (7%), Proteobacteria (6%) and Fusobacteria (3%). The abundance of H. pylori was very low and gastric cancer microbiota was instead dominated by different species of the genera Streptococcus, Lactobacillus, Veillonella and Prevotella. Remarkably, the constitution of gastric microbiota was not significantly different between gastric cancer patients and controls (p = 0.12) (24) .
In contrast to the aforementioned results, Eun et al. report significant differences in the composition and diversity of gastric microbiota among patients with gastric cancer, intestinal metaplasia and chronic gastritis, especially in the Helicobacter-dominant group. The gastric cancer group showed a significant decrease in the Epsilonproteobacteria class and Helicobacteriaceae family, while the Bacilli class and Streptococacceae family increased significantly (20) .
In addition, significant differences in the gastric microbiota profile between non-atrophic gastritis, intestinal metaplasia and intestinal type gastric cancer were recently reported by Avilés-Jiménez et al. Further analyses revealed 27 operational taxonomic units (OTU) with a difference in abundance significant across groups. From the 12 OTU with the most significant p-values (as selected by the authors), 10 displayed a clear decreasing trend from non-atrophic gastritis to intestinal metaplasia to gastric cancer (2 TM7, 2 Porphyromonas spp, 1 Neisseria spp, 1 Haemophilus spp, 1 Bulleidia spp, Prevotella pallens, Streptococcus sinensis and Bergeriella denitrificans), while 2 revealed an increasing trend (Lactobacillus coleohominis and Lachnospiraceae) (22) .
The approach taken by Khosravi et al. also aimed to provide an insight into the contribution of disease to the constitution of the gastric microbiota. The gastric microbiota was compared between patients with different gastric diseases, including non-ulcer dyspepsia (87.6%), peptic ulcer disease (10.2%) and gastric cancer (3.7%). Interestingly, the prevalence of Klebsiella pneumoniae and Acinetobacter baumannii in gastric cancer patients was 536 E. DIAS-JÁCOME ET AL.
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Rev esp enfeRm Dig 2016;108 (9):530-540 significantly higher than that in the non-ulcer dyspepsia and peptic ulcer disease groups (50% vs 18.9% and 9.10%; 25% vs. 3.2% and 4.5%, respectively). Nevertheless, these results should be considered with caution because of the low number of gastric cancer patients compared with the two other groups (19) . The presence of Bifidobacteriaceae in the hypochlorhydria stomach of 13 patients with atrophic gastritis and 10 patients receiving omeprazole was recently studied by Matarelli et al. The presence of Bifidobacteriaceae correlated significantly only in the omeprazole patients. However, bacteria belonging to the Actinomycetales order were also present and correlated significantly with both conditions (p < 0.01) (25) . It is surprising that previous studies on gastric cancer and chronic atrophic gastritis failed to detect these bacteria (20, 22, 24) . The significance of this atypical microbiota colonization remains to be studied.
The presence of Helicobacter DNA was investigated by Han et al. using a Helicobacter species-specific 16S rRNA PCR amplification and pyrosequencing analysis in 51 resected gastric adenocarcinomas. H. pylori was present in 47 (92.2%) of 51 samples. In the four of H. pylori-negative cases, two cases of Helicobacter cinaedi were detected, as well as one case of Helicobacter mustelae and one case of Campylobacter hyointestinalis. However, their role in the pathogenesis of gastric adenocarcinoma remains unclear (26) .
Taken together, these results demonstrate that there are significant differences in the constitution of gastric microbiota between the sequential steps of the cascade of carcinogenesis, such as non-atrophic gastritis, intestinal metaplasia and gastric cancer. These findings suggest that there could be a progressive shift in the constitution of the gastric microbiota during the progression of pre-malignant lesions to gastric cancer and that gastric carcinogenesis could be associated with an increase in many bacteria, as well as a decrease in others, as summarized in table II.
It is interesting to note that, globally, there is a decrease in bacteria belonging to the phyla Proteobacteria (Neisseria spp [22] , Haemophilus spp [22] , Bergeriella denitrificans [22] , Epsilonproteobacteria [20] and Helicobacteriaceae [20] ) and Bacteroidetes (Porphyromonas spp [22] and Prevotella pallens [22] ), whereas bacteria belonging to the phyla Firmicutes are either increased (Streptococacceae [20] , Lachnospiraceae [22] and Lactobacillus coleohominis [22] ) or decreased (Streptococcus sinensis [22] ). Klebsiella pneumoniae and Acinetobacter baumannii are two notable exceptions, as they belong to the phylum Proteobacteria, although they tend to increase with gastric carcinogenesis (19) . It is intriguing that one study found that Streptococcus sinensis was associated with a decreasing trend from premalignant lesions to gastric cancer (22) , whereas another study reported that its family, Streptococacceae, was increased in gastric cancer compared with intestinal metaplasia and chronic gastritis (20) .
Bacteria belonging to the other two dominant phyla, Actinobacteria and Fusobacteria, appear to play a less significant role in the process of carcinogenesis, as only one study reported a significant increase in bacteria belonging to the phyla Actinobacteria (Actinomycetales [25] ) in atrophic gastritis, whereas there are no studies reporting significant variations involving Fusobacteria.
DISCUSSION
The present systematic review shows that, even though there is little evidence in humans, there could be a progressive shift in the constitution of gastric microbiota as well as the progression from premalignant lesions to gastric cancer, and, possibly, these microorganisms play an important (as yet undetermined) role in gastric carcinogenesis, beyond the well-known influence of H. pylori. Studies regarding the role of H. pylori in the constitution of gastric microbiota have provided conflicting results, which could be related to the methods used. In fact, some of the included studies did not find significant differences using cloning (14) and culture-based approaches (19, 21) , whereas other studies report significant changes in gastric microbiota according to H. pylori status based on DNA microarrays (17) or 454-pyrosequencing (16) , which allow the study of a wider range of bacteria, thus providing a more complete view of the picture. Animal studies have also yielded contradicting findings, as H. pylori infection altered significantly the constitution of gastric microbiota in a BALB/c mice model (27) and in Mongolian gerbils (28) , but it does not significantly alter the murine gastric microbiota (29) .
Dicksved et al. contributed the first DNA-based description of a complex gastric microbiota composition in individuals with gastric cancer although it did not differ significantly between gastric cancer patients and controls. However, this study has considerable limitations, including the small sample size and lack of the most current high-throughput sequencing technology (24) . In fact, more recent studies reported significant differences in the constitution of gastric microbiota between patients with gastric cancer and premalignant lesions (20, 22) , which could be related to the method used: the study conducted by Dicksved et al. was based on cloning, sequencing and T-RFLP of 16S rRNA (24) , which has important limitations in sensitivity and coverage compared with more recently developed 16S rRNA sequencing techniques, including G3 PhyloChip (22) or 454 GS FLX Titanium (20) .
It is also interesting that some studies suggest that gastric carcinogenesis is related to low gastric microbial diversity (22, 23) , which contrasts with the increased diversity in gastric cancer patients reported by Eun et al. (20) . This could be partially explained by the fact that Yu et al. used an array primarily designed to assess oral microbiota (HOMIM), possibly excluding some bacteria from the stomach, and the lower microbial richness could actually reflect their increased abundance (23) . Nevertheless, this (20) . Both approaches are reliable to characterize gastric microbiota and this discrepancy is intriguing.
Other reviews (30) (31) (32) (33) (34) and recent studies in animal models (35-37) strongly support an important role for gastric microbiota in gastric carcinogenesis. In fact, the colonization of insulin-gastrin (INS-GAS) mice, a mouse model of gastric cancer, by a complex gastric microbiota not only increased the incidence of gastric intraepithelial neoplasia (36) , but also accelerated its development when compared with those infected by H. pylori alone (35) . In addition, antibiotic treatments had the opposite effect, delaying significantly the development of gastric intraepithelial neoplasia (37) .
Taking all these results together, one hypothesis is that gastric carcinogenesis could result from the interaction between H. pylori and gastric microbiota. H. pylori may be more important in the early stages of gastric carcinogenesis, as a trigger for the development of chronic atrophic gastritis, rather than as a direct inducer of gastric cancer. Instead, the decreased acidity secondary to mucosal atrophy would lead to changes in the constitution of gastric microbiota that could play important roles in the later stages of gastric carcinogenesis, inducing progression from chronic atrophic gastritis to intestinal metaplasia and, finally, to gastric cancer (Fig. 2) .
The link between H. pylori and gastric microbiota in the pathogenesis of gastric cancer can be related to Toll-like receptors. In fact, there is evidence that increasing activation of these receptors, initially by H. pylori and later potentially by other microorganisms, may play an important role in gastric carcinogenesis (38) .
Although our knowledge about the role of gastric microbiota in gastric carcinogenesis is only in the beginning, it looks clear that this is an area of intensive research and great future potential. In fact, since our timeline (August 2015), two more original studies have been published. Jo et al. analyzed gastric microbiota by 454-pyrosequencing of the 16S rRNA gene and reported that the number of nitrate-reducing bacteria other than H. pylori was twofold higher in the cancer group compared with the control group, but it did not reach statistical significance (39) . Another recent study, performed by Yang et al., compared gastric microbiota between two Colombian populations with very different incidences of gastric cancer (Tuquerres have a 25-fold higher risk than the Tumaco) in spite of a similar H. pylori prevalence. Interestingly, these authors found that the gastric microbiota had a significant correlation with the town of origin, with Leptotrichia wadei and Veilonella sp being significantly more common in Tuquerres and Staphylococcus sp significantly more abundant in Tumaco (40) . These results demonstrate that this is an area of intensive research and our knowledge about the role of gastric microbiota in gastric carcinogenesis will certainly progress in the near future. We believe that this systematic review provides an important starting point for future research in this area.
Perhaps further knowledge about the role of specific microorganisms in the progression of gastric premalignant lesions would allow the development of specific microbes and microbiota-based biomarkers for diagnostic and therapeutic purposes. Certain microorganisms with anti-H. pylori activity, like Lactobacillus (41, 42) or Saccharomyces boulardii (43) , could be used as a novel probiotic approach for H. pylori eradication, overcoming antibiotic-associated problems like adverse effects or resistance. Also, if a gradual shift in the gastric microbiota profile from non-atrophic gastritis to intestinal metaplasia, and then to intestinal type gastric cancer, is confirmed, perhaps a novel screening method based on searching for specific gastric microbiota profiles could be developed, allowing us to detect premalignant lesions.
This systematic review faces some limitations. There are few studies about the role of gastric microbiota in human patients and most involve a limited number of subjects and follow a cross-sectional design. Also, most studies included do not make a clear distinction between diffuse and intestinal types of gastric cancer. More studies in large prospective cohorts are needed to confirm how the human gastric microbiota may affect the development of gastric cancer. Fig. 2 . Possible mechanisms of interaction between Helicobacter pylori and gastric microbiota to induce gastric carcinogenesis. Helicobacter pylori may be more important in the early stages, as a trigger for the development of chronic atrophic gastritis. The subsequent decreased acidity would lead to an increase in certain bacterial species and a decrease in others. These changes in the constitution of gastric microbiota could play important roles in later stages of gastric carcinogenesis, inducing progression from chronic atrophic gastritis to intestinal metaplasia and, finally, to gastric cancer. Nevertheless, this study, to our knowledge, is the first systematic review summarizing the evidence regarding the influence of non-Helicobacter bacteria in the process of gastric carcinogenesis. However, current evidence does not allow us to make specific conclusions about the specific role of other bacteria in the development of gastric cancer, with many potentially being only innocent bystanders.
Normal gastric microbiota
In conclusion, the interaction between H. pylori and gastric microbiota may be a crucial step in gastric carcinogenesis. Microbiota differences between healthy individuals, pre-malignant lesions and gastric cancer have been described, and it could suggest a progressive shift in the constitution of gastric microbiota in carcinogenesis. However, the identities of specific microorganisms involved in these processes remain largely unknown and further studies clarifying their carcinogenic mechanisms are needed.
